Variability of Steady State Oral Baclofen Dosing in Pediatric Patients with Cerebral Palsy.
The primary objective of this study was to identify oral baclofen dosing variability at steady state based on weight and Gross Motor Functional Classification System (GMFCS) level using a retrospective cross-sectional study design. The medical records of 500 pediatric aged patients (age 1-21) were reviewed to obtain 144 pediatric patients who met inclusion criteria. One way ANOVA tests revealed increasing mean doses in baclofen (in mg/kg) with higher GMFCS levels (p=0.001). Post-hoc Tukey analysis showed patients with higher ambulatory ability (GMFCS I-II) received a lower total daily dosage than did patients with less ambulatory ability (GMFCS III-V). A moderate correlation was observed with increasing oral baclofen dose as weight increased (r=0.43, p<0.0001). Due to the variability in dosing between GMFCS levels, prescribing oral baclofen for pediatric patients with CP may not follow the traditional model of weight-based dosing seen in other pediatric conditions.